Skip to main content
. 2021 Sep 14;16(9):e0257397. doi: 10.1371/journal.pone.0257397

Table 4. Outcomes in patients with IC-MPGN stratified by median age (62 y) and with or without steroid pulse therapy at initial treatment.

≤ 62y > 62y P value
Steroid pulse (-) Steroid pulse (+) Steroid pulse (-) Steroid pulse (+)
N 15 19 23 10
Last urinary protein (g/day)(or g/gCr) 0.53 (0.08, 0.92) 0.09 (0.05, 0.43) 3.15 (1.15, 4.57) 2.91 (0.26, 4.55) 0.001*
Last serum creatinine (mg/dL) 0.89 (0.68, 1.79) 0.87 (0.53, 2.28) 3.37 (1.33, 5.03) 1.81 (0.84, 4.85) 0.005*
Last eGFR (mL/min/1.73 m 2 ) 58.7 ± 35.1 67.2 ± 39.9 21.9 ± 20.0 34.9 ± 30.2 0.001*
Last serum albumin (g/dL) 3.9 ± 0.8 3.8 ± 0.8 3.1 ± 0.6 3.1 ± 0.8 0.004*
Complete remission 2 (13.3) 9 (47.4) 2 (8.7) 2 (20.0) 0.038*
Serum creatinine ×1.5 2 (13.3) 7 (36.8) 17 (73.9) 3 (33.3) 0.002*
End-stage kidney disease 2 (13.3) 3 (15.8) 10 (43.5) 3 (33.3) 0.092
All-cause death 1 (6.7) 1 (5.3) 7 (30.4) 3 (13.3) 0.065

Numbers are N (%) or mean ± standard deviation or median (25%, 75%). eGFR, estimated glomerular filtration rate.

*P < 0.05 for chi-square test, or Kruskal–Wallis test, as appropriate (followed by multiple comparison test with the Bonferroni correction).

P < 0.05 for comparison of younger patients without steroid pulse therapy.